ArticleGut and liver2021

Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn's Disease.

Yoon Suk Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.